Expanding a network for pediatric critical care research
Collaborative Pediatric Critical Care Research Network - Clinical Site
['FUNDING_OTHER'] · UNIVERSITY OF UTAH · NIH-10915500
This study is looking to improve treatment for children with severe infections that affect multiple organs by testing personalized therapies in more hospitals, so young researchers can learn and help make a difference in how we care for these critically ill kids.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF UTAH (nih funded) |
| Locations | 1 site (SALT LAKE CITY, UNITED STATES) |
| Trial ID | NIH-10915500 on ClinicalTrials.gov |
What this research studies
This research aims to reorganize and expand the Collaborative Pediatric Critical Care Research Network (CPCCRN) to include more clinical sites and enhance mentorship for young investigators. The project will implement a multi-center randomized controlled trial focused on personalized immunomodulation for children suffering from sepsis-induced multiple organ dysfunction. By increasing the number of participating sites, the research seeks to gather more comprehensive data and improve treatment strategies for critically ill pediatric patients. Patients will be monitored and treated based on tailored immunomodulatory approaches to improve their outcomes.
Who could benefit from this research
Good fit: Ideal candidates for participation are children aged 0-11 years who are experiencing acute critical conditions such as sepsis or organ dysfunction.
Not a fit: Patients who are outside the age range of 0-11 years or those not experiencing acute critical conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment protocols for critically ill children, particularly those with sepsis and multiple organ dysfunction.
How similar studies have performed: Previous research has shown success with similar multi-center approaches in pediatric critical care, indicating a strong potential for impactful outcomes.
Where this research is happening
SALT LAKE CITY, UNITED STATES
- UNIVERSITY OF UTAH — SALT LAKE CITY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: AKCAN ARIKAN, AYSE — UNIVERSITY OF UTAH
- Study coordinator: AKCAN ARIKAN, AYSE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acute Lung Injury, Acute Pulmonary Injury